Tanke Financial Statements From 2010 to 2024
| TNBI Stock | USD 0.06 0.01 14.29% |
Check Tanke Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tanke main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Tanke financial statements analysis is a perfect complement when working with Tanke Biosciences Valuation or Volatility modules.
Tanke |
Tanke Biosciences Company Return On Equity Analysis
Tanke Biosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Tanke Biosciences Return On Equity | -0.1 |
Most of Tanke Biosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tanke Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Tanke Biosciences has a Return On Equity of -0.1039. This is 107.17% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The return on equity for all United States stocks is 66.48% lower than that of the firm.
Tanke Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tanke Biosciences's current stock value. Our valuation model uses many indicators to compare Tanke Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tanke Biosciences competition to find correlations between indicators driving Tanke Biosciences's intrinsic value. More Info.Tanke Biosciences is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Tanke Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tanke Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tanke Biosciences' earnings, one of the primary drivers of an investment's value.About Tanke Biosciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Tanke Biosciences income statement, its balance sheet, and the statement of cash flows. Tanke Biosciences investors use historical funamental indicators, such as Tanke Biosciences's revenue or net income, to determine how well the company is positioned to perform in the future. Although Tanke Biosciences investors may use each financial statement separately, they are all related. The changes in Tanke Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tanke Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Tanke Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Tanke Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Tanke Biosciences Corporation, through its subsidiaries, develops, produces, markets, and sells animal nutrition and feed additive products. Tanke Biosciences Corporation was founded in 1989 and is headquartered in Guangzhou, the Peoples Republic of China. TANKE BIOSCIENCES operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 130 people.
Currently Active Assets on Macroaxis
Check out the analysis of Tanke Biosciences Correlation against competitors. Note that the Tanke Biosciences information on this page should be used as a complementary analysis to other Tanke Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Tanke Pink Sheet analysis
When running Tanke Biosciences' price analysis, check to measure Tanke Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanke Biosciences is operating at the current time. Most of Tanke Biosciences' value examination focuses on studying past and present price action to predict the probability of Tanke Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanke Biosciences' price. Additionally, you may evaluate how the addition of Tanke Biosciences to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |